Preview Mode Links will not work in preview mode

Eagle's Eye View: Your Weekly CV Update From

Oct 5, 2022

In this week’s View, Dr. Eagle discusses the Fitbit Heart Study that examines the detection of atrial fibrillation in a large population using wearable devices, then looks at the long-term effects of P2Y12 inhibitor monotherapy after percutaneous coronary intervention. Finally, Dr. Eagle discusses risk assessment of hypertensive events during pregnancy.

Subscribe to Eagle’s Eye View